Immunomodulation with novel pharmaceutical compositions

Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C564S454000, C564S461000, C564S511000, C564S512000, C548S557000, C548S558000, C546S244000, C514S315000, C514S329000, C514S426000, C514S673000, C514S674000

Reexamination Certificate

active

07388112

ABSTRACT:
The synthesis and use of a novel class of tumor necrosis factor (TNFα) inhibitors and immunomodulators are provided. Examples are those having the structures:wherein a, b and c are integers from 0 to 12, X equals NH or CHNH2, R1and R2each is a hydrogen or a C1to C20aliphatic; aliphatic amine; an alicyclic; aromatic; heterocycle; and halogenated forms thereof; andwherein, a, b and c are integers from 0 to 12; R1, R2, R3, and R4each is a hydrogen or a C1to C20; aliphatic amine; an alicyclic; aromatic; a heterocycle; and halogenated forms thereof.

REFERENCES:
patent: 4507321 (1985-03-01), Raisfeld
patent: 6919483 (2005-07-01), Burns et al.
Database CAPLUS on STN, Acc. No. 2001:460157, Furtado, BR 9804481 (May 9, 2000) (abstract).
The Merck Index, 12thed. (1996), Merck & Co., Inc., Whitehouse Station, NJ, p. 8899, entry No. 8894.
Database Inst [Online], INIST Diffusion S.A.; Hasko et al: “Spermine differentially regulates the production of interleukin-12 p40 and interleukin- 10 and supresses the release of the T helper 1 cytokine interferon-gamma”, XP002450725 retrieved from HTTP://CAT.INIST.FR/?AMODELE=AFFICHEN&CPSI DT=1450762 abstract & Hasko et al.: Shock vol. 14, No. 2, 2000, pp. 144-149, Augusta, GA USA.
Zhang et al.: “Spermine inhibits proinflammatory cytokine synthesis in human mononuclear cells: A counterregulatory mechanism that restrains the immune response”, J. Exp. Med., vol. 185, No. 10, 1997, pp. 1759-1768, XP002450711 USA the whole document.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Immunomodulation with novel pharmaceutical compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunomodulation with novel pharmaceutical compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunomodulation with novel pharmaceutical compositions will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2808401

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.